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Abstract
Background: Continuing medical education (CME) is compulsory for physicians in Iran. Recent studies in Iran show that
modifications of CME elements are necessary to improve the effectiveness of the educational programmes. Other studies
point to an inappropriate, even irrational drug prescribing. Based on a needs assessment study regarding CME for general
physicians in the East Azerbaijan province in Iran, rational prescribing practice was recognized as a high priority issue.
Considering different educational methods, outcome-based education has been proposed as a suitable approach for
CME. The purpose of the study was to obtain experts' consensus about appropriate educational outcomes of rational
prescribing for general physicians in CME and developing curricular contents for this education.
Methods: The study consisted of two phases: The first phase was conducted using a two-round Delphi consensus
process to identify the outcome-based educational indicators regarding rational prescribing for general physicians in
primary care (GPs). In the second phase the agreed indicators were submitted to panels of experts for assessment and
determination of content for a CME program in the field.
Results: Twenty one learning outcomes were identified through a modified Delphi process. The indicators were used
by the panels of experts and six educational topics were determined for the CME programme and the curricular content
o f  e a c h  w a s  d e f i n e d .  T h e  t o p i c s  w e r e  1) Principles of prescription writing, 2) Adverse drug reactions, 3) Drug
interactions, 4) Injections, 5) Antibiotic therapy, and 6) Anti-inflammatory agents therapy. One of the topics was not
directly related to any outcome, raising a question about the need for a discussion on constructive alignment.
Conclusions:  Consensus on learning outcomes was achieved and an educational guideline was designed. Before
suggesting widespread use in the country the educational package should be tested in the CME context.
Published: 30 May 2008
BMC Medical Education 2008, 8:33 doi:10.1186/1472-6920-8-33
Received: 11 December 2007
Accepted: 30 May 2008
This article is available from: http://www.biomedcentral.com/1472-6920/8/33
© 2008 Esmaily et al; licensee BioMed Central Ltd. 
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), 
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.BMC Medical Education 2008, 8:33 http://www.biomedcentral.com/1472-6920/8/33
Page 2 of 8
(page number not for citation purposes)
Background
The need for continuing medical education (CME) as a
part of a medical doctor's professional development has
been recognized all over the world [1,2]. Since 1991, CME
has been compulsory for all Iranian physicians and other
health professionals.
Traditionally, general physicians working in primary care
as general practitioners (here referred to as GPs) have
obtained their CME through lectures and written materi-
als. These methods may increase their knowledge, but
there is no clear evidence that their skills or performance
are impacted [3-9].
Although outcome-based education (OBE) initially was
proposed for undergraduate medical education and train-
ing [10], it is now increasingly recognized as a useful
approach for CME [11]. OBE can influence the entire
process of education, i.e. decisions about the content, for-
mulation of aims, educational strategies, the teaching
methods, the assessment procedures and the educational
environment [10].
Several advantages have been suggested for adopting an
OBE model for medical education, such as helping to
increase the relevance of the education to the future prac-
tice of medicine. OBE allows for a wide degree of partici-
pation in the curriculum design process as well as
flexibility regarding the choice of educational strategies
used. OBE appears to be acceptable to most teachers prob-
ably because the concepts of OBE are clear, easily under-
standable, and provide a robust framework for the
curriculum [10,12].
Recent studies of CME for physicians in Iran show that
modifications of CME elements are necessary to improve
the effectiveness of the educational programs [13,14].
There are also convincing data showing excessive prescrib-
ing behaviour in Iran among GPs [15]. Some studies point
to an inappropriate, even irrational drug prescribing
[16,17]. According to an unpublished needs assessment
study about CME for GPs in the East Azerbaijan province
in Iran (2002), rational prescribing practice was recog-
nized as a high priority issue.
Given the timeliness and importance of this issue in Iran,
we are conducting a project aimed at evaluating the effec-
tiveness of using OBE on GPs knowledge, skills, attitudes,
and performance in a CME program on rational prescrib-
ing. No studies on OBE indicators for rational prescribing
were found in the literature. The aim of this study was,
therefore, to identify the appropriate outcomes and indi-
cators for rational prescribing based on expert opinions
and developing the curricular content in a CME program
for GPs.
Methods
The study was conducted between October 2005 and July
2006 in three phases. The first phase consisted of two
rounds of a Delphi process. In the second phase, panel
discussion sessions were used to further clarify, reach con-
sensus, and then prioritize the learning outcomes and
indicators. Finally, an appointed team determined con-
tent for the CME programme.
The Delphi technique was originally conceived of as a way
to obtain the opinion of experts without necessarily bring-
ing them together face to face [18]. This is what attracted
us to the method. For our study, we used a modified ver-
sion of the technique which also involved panel discus-
sions with experts in the field of rational prescribing and
CME. In the first two phases, the methodology was similar
to what has been described previously [12,19].
A questionnaire was designed consisting of potential
learning outcomes identified from a range of sources:
WHO (World Health Organization) prescribing indica-
tors [20,21], relevant documents [16,17,22,23], and top-
ics covered by CME programs on prescribing in Iran. A
small group of experts (a pharmacologist, a pharmacist,
and two medical specialists) assisted the research team in
defining a preliminary list of 16 potential outcomes with
appropriate measurement indicators for each one.
Participants
We selected 30 stakeholders who had a background from
at least one of the following categories (some represented
several categories): 1) seven experienced GPs, 2) four CME
decision makers from Iranian medical science universities
with a background in pharmacy, pharmacology, or health
management and who work for the Ministry of Health
and Medical Education (MOHME), 3) nine pharmacists,
4) seven pharmacologists, 5) six medical specialists. With
the exception of the experienced GPs, all the participants
were faculty members of four of the Universities of Medi-
cal Sciences in Iran as well as being CME trainers.
Delphi process and panel discussion
The questionnaire, with the 16 potential outcomes
including a definition of each outcome (to avoid any mis-
understanding), was sent out to the participants. The
respondents were asked if there was a need to include the
outcome in a programme on rational prescribing. They
answered using a 5-point Likert scale (1 = totally agree, 2
= partly agree, 3 = uncertain, 4 = partly disagree and 5 =
totally disagree). They were also asked to suggest any
other potential learning outcomes, based on their exper-
tise in the area.
The results of the returned questionnaires were assessed
by the research team and a second questionnaire wasBMC Medical Education 2008, 8:33 http://www.biomedcentral.com/1472-6920/8/33
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developed for the next stage of the Delphi process. It con-
sisted of the initial potential learning outcomes from
round 1 and ten new learning outcomes that had been
suggested by the experts. In this round, each member of
the study was asked to determine which of the proposed
outcomes should be included by using a 4-point scale (1
= totally agree, 2 = partly agree, 3 = partly disagree and 4
= totally disagree) to avoid uncertain answers.
The questionnaire responses were coded and frequencies
were determined using Microsoft Excel 2003 [24]. The
results of the second stage of the Delphi process were sub-
mitted to a specially assigned panel of experts comprised
of four CME decision-makers, four pharmacists or phar-
macologists, four medical specialists, three GPs, one epi-
demiologist, and the first author. The task of the panel
was to reach consensus on the final educational outcomes
and indicators and to identify a suitable team of experts to
develop the content.
Developing the content
The team responsible for content development was com-
prised of seven experienced CME trainers, all who had
participated in the panel discussion, and the first author.
They identified educational topics for an outcome-based
CME program in rational prescribing informed by the list
of outcomes and outcome indicators that were developed
from the second Delphi round. To each of these topics a
small group of experts and CME trainers was assigned,
with the task of developing the curricular content for that
topic.
The results from each of the small groups were distributed
to all the other teams one week prior to a final review
meeting. At this meeting, ideas about the curricular con-
tent were discussed and consensus was reached after a
revision of some of the topics. The final curricular content
formed the basis for the OBE educational program that
was to be used in the CME program on Rational Prescrib-
ing.
Ethical approval for the study was received from the Ethi-
cal Vetting Committee of the Iranian Ministry of Health
and Medical Education. Informed consent was given
through agreeing to participate in the different phases of
the study.
Results
The Delphi process
Completed questionnaires were returned from 21 of the
30 participants in the first round. Nine of the participants
(four medical specialists, two pharmacologists and three
pharmacists) did not answer, despite the reminder we sent
out one month later. These non-responders were con-
tacted by e-mail and/or telephone; six replied that they
were too busy to answer and three did not wish to partic-
ipate as they saw no personal benefit.
Ten new potential outcomes were added in the second
round based on the experts' suggestions. The second ques-
tionnaire was sent to the 21 experts who had answered in
the first round. All but one responded with new ratings.
Table 1 displays both the original outcomes and the ones
suggested by the participants in round 1. Some sugges-
tions were deemed to be beyond the scope of the pro-
gramme (such as the importance of using a computerized
prescription system to remedy prescribing errors and the
importance of the influence of socio-economic factors on
rational prescribing) or in conflict with course aims (for
instance, criticisms about using the generic names of
drugs) and therefore excluded from the process.
The panel discussion
The panellists finalised the learning outcomes during two
meetings based on the results of the Delphi process. They
agreed to accept all outcomes which at least four out of
five experts had agreed to. However, two outcomes
("Writing main complaint of the patient in the prescrip-
tion" and "Appropriate number of vitamins") were elimi-
nated and a part of the last outcome was expanded to
include corticosteroids. Some of the experts were critical
about using generic names because of the specific opin-
ions that both doctors and patients can have regarding dif-
ferent brands. However, citing the WHO, it was suggested
that this can be solved by adding the trade name after the
generic name if there is a particular reason to prescribe a
specific brand [21]. At the end of the second meeting, 21
learning outcomes and appropriate assessment indicators
had been identified (Table 2).
Content development
In the third phase, the team responsible for content devel-
opment divided the 21 learning outcomes into six main
areas for the educational programme: 1) Principles of pre-
scription writing, 2) Adverse drug reactions (ADR), 3)
Drug interactions, 4) Injections, 5) Antibiotic therapy,
and 6) Anti-inflammatory agents therapy
The content for each of these six topics was then devel-
oped individually by six small teams of professionals who
were experts in each topic. The curricula were distributed
and validated by all participants in the final meeting, dur-
ing which the content was finalized (Table 3).
Discussion
The Delphi technique was chosen in order to distil the
opinions of several experts and reach consensus without
geographical constraints [25] and with heterogenic
groups [26]. A panel of selected experts has been used in
other Delphi studies to identify prescribing errors in orderBMC Medical Education 2008, 8:33 http://www.biomedcentral.com/1472-6920/8/33
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to increase the validity of the findings [27,28]. We used a
modified version with panel discussions and small work-
ing groups in order to better validate the results, minimize
ambiguity, and further develop program content. The
process yielded twenty-one outcomes and their related
indicators. These included all but one of the initially pro-
posed indicators and half of the additionally suggested
ones (the indicator for name and age was divided into two
separate ones to make it easier to assess). Based on discus-
sions about the outcomes, six topic areas were identified
and curricular content for each was determined by an
expert team based on these outcomes. The content was
then validated by all the participating experts.
We began the Delphi process by creating a preliminary list
of potential learning outcomes through a literature review
and then made use of experts' opinions to develop and
prioritize these outcomes. These experts were involved in
CME either as decision makers or trainers. GPs represent-
ing the target audience were also included as a way of
improving the relevancy of the programme as has been
described previously [9]. In these ways, we aimed to
bridge the gap between the actual learning needs of indi-
vidual practitioners and the educational content that is
considered to meet assumed needs, a problem that has
been described in the educational literature [29,30].
Two of the learning outcomes which were suggested by
the experts during the Delphi process were excluded dur-
ing the panel discussions. Due to a concern that the CME
programme as a whole would be rejected if individual
parts were considered to be too controversial, the out-
come "writing main complaints of the patient in the pre-
scription" was rejected. The panellists thought that it
would be too great a departure from the current work
practice of physicians. Even though the over prescribing of
vitamins is thought to be a problem in Iran, the outcome,
"appropriate number of vitamins", was rejected since it
would be difficult to assess as most vitamins are not reim-
bursed by insurance organizations, the registries of which
Table 1: Potential learning outcomes as assessed through the Delphi process
Potential outcomes for Rational Prescribing (round 1) Agreement* (n = 21) Agreement* (n = 20)
Upon completion of the course, a doctor will be able to write a prescription that includes or considers: Round 1 Round 2
1. Date of the prescription 21 20
2. Name and age of the patient 21 20
3. Name and identification number of Iranian Medical Council of the prescriber** 21 20
4. Main complaint of the patient 11 16
5. Legible hand writing 20 20
6. Generic name of the drugs 16 18
7. Administration form of drugs 20 20
8. Strength of the drugs and dose frequency 20 20
9. Adequate duration of treatment 16 20
10. Latin abbreviation of terminology in drug use order 12 17
11. Appropriate number of drugs 16 20
12. To consider homogeneity of prescription per individual (all drugs prescribed pertain to the 
same individual)
18 19
13. Not prescribing drugs with the same pharmacological effect 14 19
14. Not prescribing drugs which have negative interactions with each other 17 19
15. Appropriate number and amount of antibiotics 19 20
16. Appropriate number of injections 17 20
Suggested potential outcomes (added in round 2)
1. Contact telephone number of the prescriber 17
2. Refill information 18
3. Initial diagnosis 15
4. Time and manner of drug use 17
5. Necessary precautions 16
6. Necessary notifications about signals to continue or stop drug use 13
7. Notification about side effects of drugs in the prescription 6
8. Name of the foods which have negative interactions on drug efficacy and the treatment 
process
8
9. Appropriate no. of NSAID (Non-steroidal anti-inflammatory) drugs 20
10. Appropriate number of vitamins 19
* Sum of the number of respondents who answered "partly agree" and "totally agree".
** Compulsory in IranBMC Medical Education 2008, 8:33 http://www.biomedcentral.com/1472-6920/8/33
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provide the best way to assess physician prescribing
behaviour in Iran.
The panel added one outcome related to the prescribing of
corticosteroids as it had been reported that corticosteroid
drugs had been prescribed more than any other drug
group in East Azerbaijan Province during the last year
(yearly report of Rational Prescribing Committee, Tabriz
University of Medical Sciences, Tabriz, Iran; 2005). The
panel also emphasized the importance of the learning
outcomes related to instructions on how to administer
medications as there is evidence that there is a large
number of prescriptions that do not include directions for
patient use [16]. These were two examples, where out-
comes from the original Delphi process were further mod-
ified or built upon with the modified Delphi process.
A comparison of the outcomes with the curricular content
of the course that was developed reveals that while all of
the outcomes are covered in the course, the entire course
is not covered by the outcomes as the topic "adverse reac-
tions to drugs" is not directly related to an outcome. ADR
can be the result of irrational prescribing. Thus, knowl-
edge about the consequences of irrational prescribing can
motivate a change in participants' behaviour. As such,
ADR can be considered integral to a course on rational
prescribing. However, if the course was supposed to be
designed using an OBE approach, why wasn't ADR identi-
fied as an outcome? Possible explanations are on the one
hand that tradition prevailed and on the other that the
specific construction of the task for the Delphi rounds had
a decisive influence.
Regarding the first explanation, a review of the topics that
were included in the curricula shows that these topics
were taught in other CME courses on prescribing. Since
the team of experts responsible for content development
all had taught according to the earlier curricula, tradition
might have prevailed despite receiving the finalized list of
outcomes and an explanation about how they were
derived.
The other more distinct and plausible explanation for why
the initial Delphi process did not elicit a topic that content
developers deemed essential could be due to the formula-
tion of the instructions for the Delphi process. The task
was to identify what should be included or considered
when the doctor writes a prescription. We believe this to
be the main reason for not suggesting ADR as an outcome
indicator as information on ADR cannot be written
directly in the prescription. However, since ADR has to be
considered before a particular drug is chosen, content
Table 2: Rational prescribing outcomes and indicators for GP's CME programmes as agreed by an expert panel
Outcomes Assessment Indicator
Upon completion of the course, a participant should be able to:
1. Write the date of the prescription 1. Date of the prescription
2. Write the name of the patient 2. Name of the patient
3. Write the age of the patient 3. Age of the patient
4. Write the name and identification number of the Iranian Medical 
Council for the prescriber
4. Name and identification number of Iranian Medical Council of the 
prescriber
5. Write the contact telephone number of prescriber 5. Contact telephone number of prescriber
6. Write refill information 6. Refill information
7. Write the prescription clearly 7. Legible hand writing
8. Write the generic name of the drugs 8. Generic names of drugs
9. Write the administration form of the drugs 9. Administration form of drugs
10. Write the strength of the drugs (dose and dose frequency) 10. Strength of the drugs
11. Write the duration of treatment 11. Treatment duration
12. Use the Latin abbreviation of terminology in drug use order 12. Use Latin abbreviation terminology
13. Write the time and manner of drug use 13. Time and manner of drug use
14. Write the necessary precautions 14. Necessary precautions
15. Prescribe the appropriate number of drugs 15. Appropriate number of drugs
16. Consider homogeneity of prescription per individual (all drugs 
prescribed pertain to the same individual)
16. Homogeneity of prescriptions
17. Avoid prescribing drugs with the same pharmacological effect 17. Number of drugs in the same pharmacological group
18. Avoid prescribing drugs which have negative interactions with each 
other
18. Number of interactive drugs per prescription
19. Prescribe the appropriate number and amount of antibiotics 19. Number and amount of antibiotics per prescription and proportion 
of antibiotics prescribed
20. Prescribe the appropriate number of injections 20. Number of injections per prescription and proportion of injections 
prescribed
21. Prescribe the appropriate number of Anti-Inflammatory Agents 
[Corticosteroids and Non-steroidal anti-inflammatory drugs (NSAID)]
21. Appropriate number of Anti-Inflammatory Agents [Corticosteroids 
and Non-steroidal anti-inflammatory drugs (NSAID)]BMC Medical Education 2008, 8:33 http://www.biomedcentral.com/1472-6920/8/33
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developers included this topic in the curriculum. While it
would have been possible to develop direct outcomes and
indicators for ADR, ADR can be seen to indirectly be part
of and important in achieving some of the other out-
comes, such as avoiding prescribing drugs with negative
interactions or similar effects or prescribing injections too
frequently.
A final observation was that the constructive alignment
approach [31], where outcomes are tied together with
content and assessment methods, was not expressly dis-
cussed during the third phase of content development.
This could mean that content developers were simply
unaware of the need to explicitly link outcomes to course
content and could thus benefit from more knowledge
about outcome-based education and constructive align-
ment prior to designing courses.
Another question concerns the quality of the outcomes
and the indicators that were formulated. Outcomes can be
analyzed based on how specific they are, if they are meas-
urable, if they cover the domains of knowledge, skills, and
attitudes, and if they are of a manageable number [32].
Most of the outcomes meet these criteria. However, the
word "appropriate" (found in outcomes 15 and 19–21) is
harder to measure, although it would be possible to meas-
ure if linked to clear guidelines. According to the ideas
behind outcome-based education and constructive align-
ment, the validated indicators could form the basis for
assessment of GPs' performance and provide them with
feedback on the effectiveness of their learning. This could
be pursued in further research.
Conclusion
The modified Delphi process was effective in developing
outcomes and indicators that were then used in the devel-
opment of content for a course in rational prescribing. The
Table 3: Curricular content for the programme on rational prescribing as developed by teams of CME trainers.
Topics for the rational prescribing curriculum
1-Principles of prescription writing (1–16)* 5-Antibiotic therapy (19)
History of prescription writing Value of taking culture samples for infections
Classification of drugs Assessment of infectious organisms
Definition and format Importance of host factors in selection of
Elements of prescription writing antibiotics
Measurements Adherence to correct indications
Mistakes and errors in prescription writing Selection of antibacterial drug(s)
Abbreviations Important factors for choosing form, dose and
Poor prescriptions course of antibiotics
Rational prescriptions Importance of switching antibiotics based on
2-Adverse reactions to drugs culture and antibiogram results
Background Pharmacology of antibiotic groups:
Epidemiology m Betalactamases
Etiology m Tetracyclines
Exaggeration of an intended pharmacologic m Aminoglycosides
action of the drugs m Macrolides
Toxicity unrelated to a drug's primary m Fluoroquinolones
pharmacological activity: m Sulfonamides
- Cytotoxic Reactions 6- Anti-inflammatory agents therapy (21)
- Immunologic Mechanisms A) Corticosteroids
Diagnosis and treatment of adverse drug Indications
reactions Emphasis on reducing injections
3- Drug Interactions (17, 18) Adverse effects
Important mechanisms of drug interactions Important interactions
Common drug interactions in the practice of B) Non steroidal anti inflammatory drugs
general physicians (NSAIDs)
4- Injections (20) Indications
Consideration of real needs for prescribing Adverse effects
injections Drug Interactions
Mechanism of injections Contraindications
Indications for injections
Important factors in prescribing injections
Prevalence of prescribing injections in the
world and in Iran
* Numbers in parentheses refer to the related outcomes.BMC Medical Education 2008, 8:33 http://www.biomedcentral.com/1472-6920/8/33
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indicators can be used to assess what participants have
learned during the course as well as prescribing behaviour
after the course. To improve the constructive alignment of
the course, course developers should understand that out-
comes need to be explicitly related to course curricula.
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